Intranasal NAD+ spray,
does it really help with Improved daily energy and focus and reduced fatigue through nasal absorption?
research showsIntranasal NAD+ spray is rated ? because no completed human intervention result was found for energy, focus, or fatigue with this formulation. Studies of oral NR or NMN, intravenous NAD+, injections, or patches involve different exposure and cannot substitute. A 2026-registered combination study that includes intranasal NAD+ uses several interventions and has no posted efficacy results, so it does not establish finished-product efficacy. Absence of literature is not proof of ineffectiveness.
ads claimSellers claim direct nose-to-brain delivery, instant cellular energy, and a focus boost, but human nasal absorption and clinical benefit have not been established. Oral-precursor trials and cellular metabolism explanations are not evidence for the nasal finished product.
Useful facts when choosing a product
- NAD+ is a coenzyme in cellular redox and energy metabolism, but its essential endogenous role does not automatically establish benefit from exogenous nasal dosing.
- Cross-border nasal sprays may be unapproved wellness products, with product-to-product variation in content, purity, sterility, preservatives, and delivered dose.
- Human nasal safety data are inadequate to quantify burning, irritation, epistaxis, worsened rhinitis, contamination risk, or long-term harms.
What the research actually shows
Human trials of oral NR and NMN have mainly assessed blood NAD+ metabolites and safety, with inconsistent clinical energy or cognitive benefits. No completed human result was found that jointly evaluated intranasal NAD+ absorption, pharmacokinetics, dose, nasal safety, and the claimed wellness outcomes. ClinicalTrials.gov entry NCT07475546 includes intranasal NAD+ 30 mg/day together with low-dose naltrexone, vitamin B12, metformin, and other interventions; no results were posted by the verification date.
Why this is classified as ?
There is no completed human intervention for the exact formulation-outcome pair. Under boundary rule ④, evidence from other routes or precursors is not extrapolated, giving ? with a null score.
Counterpoint. Persistent fatigue or poor concentration has many causes, including sleep disorders, anemia, thyroid disease, depression or anxiety, and medicines; evaluating the cause takes priority.
Rejudgment record. New verdict — There is no completed human intervention for the exact formulation-outcome pair. Under boundary rule ④, evidence from other routes or precursors is not extrapolated, giving ? with a null score.
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Improved daily energy | ? | No completed human intervention result was found for an intranasal NAD+ finished product. |
| Improved focus | ? | No result publication tested objective or subjective focus with this formulation. |
| Reduced fatigue | ? | No human trial result evaluated fatigue reduction from intranasal NAD+ alone. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| ClinicalTrials.gov NCT07475546 | Registered multi-intervention exploratory study | To be reported | Composite healthspan outcomes; not an isolated intranasal NAD+ effect | Includes intranasal NAD+ with multiple co-interventions and had no results by the verification date. | Evidence-gap context rather than efficacy evidence | |
| Covarrubias AJ et al. 2021 | Narrative review of NAD+ metabolism, aging, and clinical translation | Academic research support | NAD+ biology and clinical evidence for augmentation strategies | Human evidence largely concerns oral precursors, while clinical benefits and tissue effects remain unresolved. | Limits extrapolation from other formulations |
Receipt — 3 References
All 3 cited sources were verified for existence at the original page (as of 2026-07-23).
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-23 · Corrections: none
Cite this verdict
[Chamgap] Intranasal NAD+ spray x Improved daily energy and focus and reduced fatigue through nasal absorption — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/energy/intranasal-nad-spray-energy-focus-fatigue/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.